Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Assess which Dividend Aristocrats ETF offers the lowest expenses while maintaining solid diversification and dividend potential for your portfolio.
27,511 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Marvell Technology shows signs of narrowing Broadcom's AI revenue lead as data-center demand accelerates, sparking re...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Wall Street is backing tokenized real-world assets on Ethereum, cementing ETH as a core platform for on-chain finance...
Vinod Khosla stepped in after Elon Musk pulled back from OpenAI’s pledge, funding a high-stakes bet that transformed ...
As the world watches the Strait of Hormuz, Canada’s Pacific energy links rise in importance. Kitimat LNG and the Tran...
Aster Chain today unveiled its mainnet, promising default privacy and CEX-like performance for DeFi traders. The laun...
Alibaba shares slid about 7% after quarterly results, underscoring a push into AI and cloud infrastructure. Investors...
Thinking long-term about crypto? This guide highlights the best cryptocurrencies right long-term bets and shows you h...
Balancer Labs will shut down after a $128 million exploit, pushing the protocol toward decentralized governance as th...
Suburban homeowners and renters are rethinking political loyalties as housing costs bite and local zoning fights esca...
Uber reports record cash flow and a bold autonomous-vehicle push as investors wonder if the uber stock price predicti...